Host immune responses to salivary gland administration of recombinant adeno-associated virus serotype 2 vectors

被引:0
|
作者
MR Kok
A Voutetakis
S Yamano
J Wang
A Cotrim
H Katano
I Bossis
JA Chiorini
PP Tak
BJ Baum
机构
[1] NIDCR,Gene Therapy and Therapeutics Branch
[2] NIH,Division of Clinical Immunology and Rheumatology, AMC
[3] DHHS,undefined
[4] University of Amsterdam,undefined
来源
关键词
Salivary Gland; Submandibular Gland; Host Immune Response; Human Growth Hormone; Salivary Flow;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Integration of adeno-associated virus (AAV) and recombinant AAV vectors
    McCarty, DM
    Young, SM
    Samulski, RJ
    ANNUAL REVIEW OF GENETICS, 2004, 38 : 819 - 845
  • [32] Development and targeting of recombinant adeno-associated virus (rAAV) vectors
    Hallek, M
    Girod, A
    Büning, H
    Ried, M
    Leike, K
    Hutter, M
    Huttner, N
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S33 - S33
  • [33] Biodistribution and safety profile of recombinant adeno-associated virus serotype 6 vectors following intravenous delivery
    Stone, Daniel
    Liu, Ying
    Li, Zong-Yi
    Strauss, Robert
    Finn, Eric E.
    Allen, James M.
    Chamberlain, Jeffrey S.
    Lieber, Andre
    JOURNAL OF VIROLOGY, 2008, 82 (15) : 7711 - 7715
  • [34] Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors
    Chen, SF
    Kapturczak, M
    Loiler, SA
    Zolotukhin, S
    Glushakova, OY
    Madsen, KM
    Samulski, RJ
    Hauswirth, WW
    Campbell-Thompson, M
    Berns, KI
    Flotte, TR
    Atkinson, MA
    Tisher, CC
    Agarwal, A
    HUMAN GENE THERAPY, 2005, 16 (02) : 235 - 247
  • [35] Gene delivery and serotype tropism using recombinant adeno-associated virus vectors in colonic epithelial cells
    Polyak, S
    Mah, C
    Valentine, JF
    GASTROENTEROLOGY, 2004, 126 (04) : A301 - A301
  • [36] Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases
    Li, Leyao
    Vasan, Lakshmy
    Kartono, Bryan
    Clifford, Kevan
    Attarpour, Ahmadreza
    Sharma, Raghav
    Mandrozos, Matthew
    Kim, Ain
    Zhao, Wenda
    Belotserkovsky, Ari
    Verkuyl, Claire
    Schmitt-Ulms, Gerold
    BIOMEDICINES, 2023, 11 (10)
  • [37] Recombinant adeno-associated virus vectors in the treatment of rare diseases
    Hastie, Eric
    Samulski, R. Jude
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (06): : 675 - 689
  • [38] A simplified purification protocol for recombinant adeno-associated virus vectors
    Potter, Mark
    Lins, Bridget
    Mietzsch, Mario
    Heilbronn, Regine
    Van Vliet, Kim
    Chipman, Paul
    Agbandje-McKenna, Mavis
    Cleaver, Brian D.
    Clement, Nathalie
    Byrne, Barry J.
    Zolotukhin, Sergei
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2014, 1 : 14034
  • [39] Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 Vectors: The Final Threshold?
    Aslanidi, George
    Rivers, Angela
    Ortiz, Luis
    Ling, Chen
    Van Vliet, Kim
    Govindasamy, Lakshmanan
    Agbandje-McKenna, Mavis
    Srivastava, Arun
    MOLECULAR THERAPY, 2013, 21 : S129 - S129
  • [40] Pre-clinical assessment of immune responses to adeno-associated virus (AAV) vectors
    Basner-Tschakarjan, Etiena
    Bijjiga, Enoch
    Martino, Ashley T.
    FRONTIERS IN IMMUNOLOGY, 2014, 5